The past 5–10 years have brought in a new era in the care of patients with thyroid cancer,
with the introduction of transformative diagnostic and management options. Several …

Context Low-risk differentiated thyroid cancer (DTC) is overdiagnosed, but true incidence
has increased as well. Owing to its excellent prognosis with low morbidity and mortality …

The number of cancer survivors continues to increase in the United States due to the growth
and aging of the population as well as advances in early detection and treatment. To assist …

Purpose: The determinants of response or resistance to radioiodine (RAI) are unknown. We
aimed to identify genomic and transcriptomic factors associated with structural responses to …

Background: Before the development of antithyroid drugs in the 1940s, treatment of Graves'
hyperthyroidism was primarily surgical. Surgical mortality was quite variable, but a …

Background We aimed to investigate whether the risk of second primary malignancy (SPM)
in patients with thyroid cancer (TC) receiving radioactive iodine (RAI) therapy rises in a …

Differentiated thyroid carcinoma (DTC) is the most common endocrine cancer. Particularly
the incidence of small clinically indolent tumors has been increasing significantly during the …

With its high incidence and mortality rates, cancer is one of the largest health problems
worldwide. Investigating various cancer treatment options has been the focus of many …

Simple Summary Radioactive iodine treatment is the oldest targeted therapy for
differentiated thyroid cancer. It can be used for normal thyroid remnant ablation (in order to …

Objective: This review article summarises the latest evidence for preventive central lymph
node dissection in patients with papillary thyroid cancer taking into account the possible …